Copyright Reports & Markets. All rights reserved.

Global DPT Vaccination Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global DPT Vaccination Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 DTaP
    • 1.3.3 Tdap
    • 1.3.4 DTwP
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global DPT Vaccination Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 12 Months Below
    • 1.4.3 12 Months Above
  • 1.5 Global DPT Vaccination Market Size & Forecast
    • 1.5.1 Global DPT Vaccination Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global DPT Vaccination Sales Quantity (2020-2031)
    • 1.5.3 Global DPT Vaccination Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Sanofi Pasteur
    • 2.1.1 Sanofi Pasteur Details
    • 2.1.2 Sanofi Pasteur Major Business
    • 2.1.3 Sanofi Pasteur DPT Vaccination Product and Services
    • 2.1.4 Sanofi Pasteur DPT Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Sanofi Pasteur Recent Developments/Updates
  • 2.2 GSK
    • 2.2.1 GSK Details
    • 2.2.2 GSK Major Business
    • 2.2.3 GSK DPT Vaccination Product and Services
    • 2.2.4 GSK DPT Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 GSK Recent Developments/Updates
  • 2.3 Mitsubishi Tanabe Pharma
    • 2.3.1 Mitsubishi Tanabe Pharma Details
    • 2.3.2 Mitsubishi Tanabe Pharma Major Business
    • 2.3.3 Mitsubishi Tanabe Pharma DPT Vaccination Product and Services
    • 2.3.4 Mitsubishi Tanabe Pharma DPT Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
  • 2.4 KM Biologics
    • 2.4.1 KM Biologics Details
    • 2.4.2 KM Biologics Major Business
    • 2.4.3 KM Biologics DPT Vaccination Product and Services
    • 2.4.4 KM Biologics DPT Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 KM Biologics Recent Developments/Updates
  • 2.5 Wuhan Institute of Biological Products
    • 2.5.1 Wuhan Institute of Biological Products Details
    • 2.5.2 Wuhan Institute of Biological Products Major Business
    • 2.5.3 Wuhan Institute of Biological Products DPT Vaccination Product and Services
    • 2.5.4 Wuhan Institute of Biological Products DPT Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
  • 2.6 Walvax Biotechnology
    • 2.6.1 Walvax Biotechnology Details
    • 2.6.2 Walvax Biotechnology Major Business
    • 2.6.3 Walvax Biotechnology DPT Vaccination Product and Services
    • 2.6.4 Walvax Biotechnology DPT Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Walvax Biotechnology Recent Developments/Updates
  • 2.7 Chengdu Institute of Biological Products
    • 2.7.1 Chengdu Institute of Biological Products Details
    • 2.7.2 Chengdu Institute of Biological Products Major Business
    • 2.7.3 Chengdu Institute of Biological Products DPT Vaccination Product and Services
    • 2.7.4 Chengdu Institute of Biological Products DPT Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
  • 2.8 Minhai Biotechnology
    • 2.8.1 Minhai Biotechnology Details
    • 2.8.2 Minhai Biotechnology Major Business
    • 2.8.3 Minhai Biotechnology DPT Vaccination Product and Services
    • 2.8.4 Minhai Biotechnology DPT Vaccination Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Minhai Biotechnology Recent Developments/Updates

3 Competitive Environment: DPT Vaccination by Manufacturer

  • 3.1 Global DPT Vaccination Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global DPT Vaccination Revenue by Manufacturer (2020-2025)
  • 3.3 Global DPT Vaccination Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of DPT Vaccination by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 DPT Vaccination Manufacturer Market Share in 2024
    • 3.4.3 Top 6 DPT Vaccination Manufacturer Market Share in 2024
  • 3.5 DPT Vaccination Market: Overall Company Footprint Analysis
    • 3.5.1 DPT Vaccination Market: Region Footprint
    • 3.5.2 DPT Vaccination Market: Company Product Type Footprint
    • 3.5.3 DPT Vaccination Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global DPT Vaccination Market Size by Region
    • 4.1.1 Global DPT Vaccination Sales Quantity by Region (2020-2031)
    • 4.1.2 Global DPT Vaccination Consumption Value by Region (2020-2031)
    • 4.1.3 Global DPT Vaccination Average Price by Region (2020-2031)
  • 4.2 North America DPT Vaccination Consumption Value (2020-2031)
  • 4.3 Europe DPT Vaccination Consumption Value (2020-2031)
  • 4.4 Asia-Pacific DPT Vaccination Consumption Value (2020-2031)
  • 4.5 South America DPT Vaccination Consumption Value (2020-2031)
  • 4.6 Middle East & Africa DPT Vaccination Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global DPT Vaccination Sales Quantity by Type (2020-2031)
  • 5.2 Global DPT Vaccination Consumption Value by Type (2020-2031)
  • 5.3 Global DPT Vaccination Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global DPT Vaccination Sales Quantity by Application (2020-2031)
  • 6.2 Global DPT Vaccination Consumption Value by Application (2020-2031)
  • 6.3 Global DPT Vaccination Average Price by Application (2020-2031)

7 North America

  • 7.1 North America DPT Vaccination Sales Quantity by Type (2020-2031)
  • 7.2 North America DPT Vaccination Sales Quantity by Application (2020-2031)
  • 7.3 North America DPT Vaccination Market Size by Country
    • 7.3.1 North America DPT Vaccination Sales Quantity by Country (2020-2031)
    • 7.3.2 North America DPT Vaccination Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe DPT Vaccination Sales Quantity by Type (2020-2031)
  • 8.2 Europe DPT Vaccination Sales Quantity by Application (2020-2031)
  • 8.3 Europe DPT Vaccination Market Size by Country
    • 8.3.1 Europe DPT Vaccination Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe DPT Vaccination Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific DPT Vaccination Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific DPT Vaccination Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific DPT Vaccination Market Size by Region
    • 9.3.1 Asia-Pacific DPT Vaccination Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific DPT Vaccination Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America DPT Vaccination Sales Quantity by Type (2020-2031)
  • 10.2 South America DPT Vaccination Sales Quantity by Application (2020-2031)
  • 10.3 South America DPT Vaccination Market Size by Country
    • 10.3.1 South America DPT Vaccination Sales Quantity by Country (2020-2031)
    • 10.3.2 South America DPT Vaccination Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa DPT Vaccination Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa DPT Vaccination Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa DPT Vaccination Market Size by Country
    • 11.3.1 Middle East & Africa DPT Vaccination Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa DPT Vaccination Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 DPT Vaccination Market Drivers
  • 12.2 DPT Vaccination Market Restraints
  • 12.3 DPT Vaccination Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of DPT Vaccination and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of DPT Vaccination
  • 13.3 DPT Vaccination Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 DPT Vaccination Typical Distributors
  • 14.3 DPT Vaccination Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global DPT Vaccination market size was valued at US$ 5728 million in 2024 and is forecast to a readjusted size of USD 7228 million by 2031 with a CAGR of 3.4% during review period.
    The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global DPT Vaccination market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global DPT Vaccination market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global DPT Vaccination market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global DPT Vaccination market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
    Global DPT Vaccination market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for DPT Vaccination
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global DPT Vaccination market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi Pasteur, GSK, Mitsubishi Tanabe Pharma, KM Biologics, Wuhan Institute of Biological Products, Walvax Biotechnology, Chengdu Institute of Biological Products, Minhai Biotechnology, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    DPT Vaccination market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    DTaP
    Tdap
    DTwP
    Market segment by Application
    12 Months Below
    12 Months Above
    Major players covered
    Sanofi Pasteur
    GSK
    Mitsubishi Tanabe Pharma
    KM Biologics
    Wuhan Institute of Biological Products
    Walvax Biotechnology
    Chengdu Institute of Biological Products
    Minhai Biotechnology
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe DPT Vaccination product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of DPT Vaccination, with price, sales quantity, revenue, and global market share of DPT Vaccination from 2020 to 2025.
    Chapter 3, the DPT Vaccination competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the DPT Vaccination breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and DPT Vaccination market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of DPT Vaccination.
    Chapter 14 and 15, to describe DPT Vaccination sales channel, distributors, customers, research findings and conclusion.

    Buy now